Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 On combining antineoplastic drugs with tumor vaccines.

Literature DB >> 12955481

On combining antineoplastic drugs with tumor vaccines.

Alicia Terando¹, James J Mulé.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2003 PMID： 12955481 DOI： 10.1007/s00262-003-0426-3

Source DB: PubMed Journal: Cancer Immunol Immunother ISSN： 0340-7004 Impact factor: 6.968

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

Review 1. Tumor immunity via homeostatic T cell proliferation: mechanistic aspects and clinical perspectives.

Authors: Roberto Baccala; Rosana Gonzalez-Quintial; Wolfgang Dummer; Argyrios N Theofilopoulos
Journal: Springer Semin Immunopathol Date: 2005-01-22

2. Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine.

Authors: Aaron J Schueneman; Elizabeth A Sugar; Jennifer Uram; Elaine Bigelow; Joseph M Herman; Barish H Edil; Elizabeth M Jaffee; Lei Zheng; Daniel A Laheru
Journal: Ann Surg Oncol Date: 2013-09-18 Impact factor: 5.344

Review 3. Promising novel immunotherapies and combinations for prostate cancer.

Authors: Philip M Arlen; Mahsa Mohebtash; Ravi A Madan; James L Gulley
Journal: Future Oncol Date: 2009-03 Impact factor: 3.404

4. A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.

Authors: Philip M Arlen; James L Gulley; Catherine Parker; Lisa Skarupa; Mary Pazdur; Dennis Panicali; Patricia Beetham; Kwong Y Tsang; Douglas W Grosenbach; Jarett Feldman; Seth M Steinberg; Elizabeth Jones; Clara Chen; Jennifer Marte; Jeffrey Schlom; William Dahut
Journal: Clin Cancer Res Date: 2006-02-15 Impact factor: 12.531

5. Enhanced therapeutic effect of B cell-depleting anti-CD20 antibodies upon combination with in-situ dendritic cell vaccination in advanced lymphoma.

Authors: S Manzur; S Cohen; J Haimovich; N Hollander
Journal: Clin Exp Immunol Date: 2012-12 Impact factor: 4.330

On combining antineoplastic drugs with tumor vaccines.

Review 1. Tumor immunity via homeostatic T cell proliferation: mechanistic aspects and clinical perspectives.

2. Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine.

Review 3. Promising novel immunotherapies and combinations for prostate cancer.

4. A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.

5. Enhanced therapeutic effect of B cell-depleting anti-CD20 antibodies upon combination with in-situ dendritic cell vaccination in advanced lymphoma.

6. Intratumoral dendritic cells and chemoradiation for the treatment of murine squamous cell carcinoma.

Review 7. Cancer vaccines: current directions and perspectives in prostate cancer.

Review 8. Current perspectives in prostate cancer vaccines.